Daniel Hartnett, associate managing director of the Compliance Risk & Diligence Practice of Kroll, advises on the steps that pharmaceutical companies should take to reduce the risk of dealing with third parties, as they develop a COVID-19 vaccine.

Isabelle Glimcher, a fellow at the NYU Stern Center for Business and Human Rights, recommends six steps that government procurement officials should be taking to prevent workers’ rights abuses by suppliers.

Theo Smid, economist with trade credit insurer Atradius, discusses the results of the firm’s recent forecast of corporate insolvencies for 2020.

The digital transformation of supply chains has been underway since 2010, but COVID-19 kicked it into top gear.

As part of the Food Safety Modernization Act (FSMA), the U.S. Food and Drug Administration has issued a new rule requiring stricter controls over the monitoring of food products throughout the supply chain.